Newsroom

Sorted by: Latest

-

Tredegar Announces the Retirement of Frasier W. Brickhouse II, Chief Financial Officer, Treasurer and Vice President, Effective September 1, 2026

RICHMOND, Va.--(BUSINESS WIRE)--TREDEGAR ANNOUNCES THE RETIREMENT OF FRASIER W. BRICKHOUSE II, CHIEF FINANCIAL OFFICER, TREASURER AND VICE PRESIDENT, EFFECTIVE SEPTEMBER 1, 2026...
-

Acadia Pharmaceuticals to Participate in the Canaccord Genuity 46th Annual Growth Conference

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 46th Annual Growth Conference on Wednesday, August 12, 2026 at 1:30 p.m. Eastern Time. Live webcasts will be accessible on the company’s website, acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following each presentation. About Acadia Pharmaceuticals Acadia is commit...
-

Kingswood Capital Management raccoglie 4 miliardi di dollari attraverso due fondi dedicati al mercato delle medie imprese, entrambi con sottoscrizioni superiori all'obiettivo

LOS ANGELES--(BUSINESS WIRE)--Kingswood Capital Management, L.P. (assieme alle sue consociate, "Kingswood"), una società di investimento con sede a Los Angeles che si concentra sul mercato delle medie imprese, ha annunciato oggi il closing finale di Kingswood Capital Opportunities Fund IV, L.P. (assieme al suo fondo parallelo, "Fund IV"), con impegni totali di capitale di 3,1 miliardi di dollari, nonché di Kingswood Capital Opportunities Small Cap Fund I, L.P. (assieme al suo fondo parallelo "S...
-

Kingswood Capital Management sammelt 4 Milliarden US-Dollar in zwei überzeichneten Fonds für mittelständische Unternehmen ein

LOS ANGELES--(BUSINESS WIRE)--Kingswood Capital Management, L.P. (zusammen mit seinen verbundenen Unternehmen „Kingswood“), eine in Los Angeles ansässige Investmentgesellschaft mit Schwerpunkt auf dem Mittelstand, gab heute den endgültigen Abschluss des Kingswood Capital Opportunities Fund IV, L.P. (zusammen mit seinem Parallelfonds „Fund IV“) mit Kapitalzusagen in Höhe von insgesamt 3,1 Milliarden US-Dollar sowie des „Kingswood Capital Opportunities Small Cap Fund I, L.P.“ (zusammen mit seinem...
-

Hideaway Hills Homeowners Ask South Dakota Supreme Court to Rehear Subdivision Sinkhole Case

RAPID CITY, S.D.--(BUSINESS WIRE)--Attorneys for Hideaway Hills homeowners have asked the South Dakota Supreme Court to rehear a ruling that invalidates claims seeking to hold the State responsible for areas of instability that have left the Black Hawk-area subdivision virtually uninhabitable. “We appreciate the court’s focus on the questions of inverse condemnation. However, its July 9 opinion in this case is inconsistent with both its own prior opinions and the South Dakota Constitution,” sai...
-

Resumen: One Biosciences anuncia los datos que validan un nuevo método para la elaboración de perfiles transcriptómicos tumorales a nivel unicelular a partir de muestras de anatomía patológica clínica

PARÍS--(BUSINESS WIRE)--One Biosciences, una empresa de biotecnología pionera en el análisis de perfiles tumorales a nivel unicelular de grado clínico, ha anunciado hoy unos datos que demuestran que es posible generar perfiles de expresión de ARN a nivel unicelular a partir de muestras patológicas estándar fijadas en formalina e incluidas en parafina (FFPE), obtenidas en la atención oncológica habitual, utilizando la plataforma patentada de la empresa, OneMap™. El estudio, realizado en colabora...
-

Backblaze Announces Date of Investor Day 2026

SAN FRANCISCO--(BUSINESS WIRE)--Backblaze, Inc. (Nasdaq: BLZE), the storage platform powering AI infrastructure, today announced that it will host an Investor Day on Wednesday, September 9, 2026. The event is expected to start at 9:30 a.m. Eastern time (6:30 a.m. Pacific time).The Investor Day will provide an update on Backblaze's strategy and role in the AI ecosystem. The event will be held in New York, NY. Institutional investors and financial analysts interested in attending in person should...
-

Creative Solutions in Healthcare Renews Strategic Partnership with QRM Following Seven Years of Clinical & Operational Success.

FORT WORTH, Texas--(BUSINESS WIRE)--Creative Solutions in Healthcare (CSNHC) has renewed its partnership with Quality Rehab Management (QRM), a Focal Point Care company, for an additional three-year term, extending a successful collaboration that has supported CSNHC’s in-house therapy model, strengthened facility-level performance and enhanced resident outcomes throughout its skilled nursing communities. The renewed agreement reflects CSNHC’s confidence in the value and support QRM delivers. Th...
-

One Biosciences gibt Daten bekannt, die eine neue Methode zur transkriptomischen Einzelzell-Tumorprofilierung anhand klinisch-pathologischer Proben validieren

PARIS--(BUSINESS WIRE)--One Biosciences, ein Techbio-Unternehmen, das Pionierarbeit im Bereich der klinischen Einzelzell-Tumorprofilierung leistet, gab heute Daten bekannt, die belegen, dass sich mithilfe der firmeneigenen Plattform OneMap™ Einzelzell-RNA-Expressionsprofile aus den in der routinemäßigen Krebsversorgung gewonnenen, standardmäßigen, formalinfixierten und in Paraffin eingebetteten (FFPE) pathologischen Proben erstellen lassen. Die Studie, die in Zusammenarbeit mit Forschern des Ce...
-

CBIZ Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CBIZ, Inc. - CBIZ

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CBIZ, Inc. (NYSE: CBIZ) to Grant Thornton Advisors LLC. Under the terms of the proposed transaction, shareholders of CBIZ will receive $55.00 in cash for each share of CBIZ that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether t...